Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

LQDA

Liquidia Corp

Feb 06 • 04:00PM ET

43.04

+1.48 3.56 %

Healthcare • Biotechnology • USA • NASD

Peers: REGN VRTX ALNY SRPT NBIX ARWR IONS RGEN MDGL XNCR

| Held by: VTI IWM VXF IWO PJP SCHA VTWO KOMP IHE XPH

Index	RUT	P/E	-	EPS (ttm)	-1.43	Insider Own	17.65%	Shs Outstand	86.82M	Perf Week	1.53%
Market Cap	3.74B	Forward P/E	21.51	EPS next Y	2.00	Insider Trans	-7.86%	Shs Float	71.64M	Perf Month	38.88%
Enterprise Value	3.79B	PEG	-	EPS next Q	0.19	Inst Own	71.86%	Short Float	17.71%	Perf Quarter	62.91%
Income	-121.85M	P/S	54.09	EPS this Y	56.79%	Inst Trans	0.19%	Short Ratio	6.99	Perf Half Y	124.05%
Sales	69.22M	P/B	169.45	EPS next Y	378.99%	ROA	-46.08%	Short Interest	12.69M	Perf YTD	24.79%
Book/sh	0.25	P/C	23.77	EPS next 5Y	-	ROE	-183.82%	52W High	46.67 -7.78%	Perf Year	173.44%
Cash/sh	1.81	P/FCF	-	EPS past 3/5Y	-33.51% 8.44%	ROIC	-73.96%	52W Low	11.26 282.24%	Perf 3Y	573.55%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.36% 11.64%	Gross Margin	87.62%	Volatility	6.72% 8.31%	Perf 5Y	1470.80%
Dividend TTM	-	EV/Sales	54.69	EPS Y/Y TTM	11.91%	Oper. Margin	-154.98%	ATR (14)	2.65	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.96	Sales Y/Y TTM	343.41%	Profit Margin	-176.04%	RSI (14)	59.12	Recom	1.44
Dividend Gr. 3/5Y	- -	Current Ratio	2.20	EPS Q/Q	86.17%	SMA20	4.95%	Beta	0.49	Target Price	45.67
Payout	-	Debt/Eq	9.03	Sales Q/Q	1121.72%	SMA50	18.05%	Rel Volume	0.83	Prev Close	41.56
Employees	157	LT Debt/Eq	6.47	Earnings	Nov 03 BMO	SMA200	75.50%	Avg Volume	1.82M	Price	43.04
IPO	Jul 26, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	89.73% 188.24%	Trades		Volume	1,503,837	Change	3.56%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-25	Initiated	Wells Fargo	Overweight	$31
Aug-15-25	Resumed	Jefferies	Buy	$43
May-19-25	Downgrade	Oppenheimer	Perform → Underperform	$13
Dec-20-24	Initiated	Wells Fargo	Overweight	$20
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform	$27
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy	$18 → $28
Sep-19-22	Resumed	Wedbush	Underperform	$3
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform	$3
Jul-22-22	Initiated	Ladenburg Thalmann	Buy	$15
May-31-22	Initiated	BTIG Research	Buy	$14
May-26-22	Initiated	BofA Securities	Buy	$12
Dec-04-20	Initiated	H.C. Wainwright	Buy	$6
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral	$20 → $4
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform	$26
Aug-20-18	Initiated	Needham	Buy	$30
Aug-20-18	Initiated	Jefferies	Buy	$22

Show Previous Ratings

Jan-27-26 08:30AM	Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress (GlobeNewswire)
Jan-16-26 08:29AM	Laughing Water Capital's Updates on Liquidia Corp (LQDA) (Insider Monkey)
Jan-15-26 12:00PM	Liquidia Corporation (LQDA) is a Great Momentum Stock: Should You Buy? (Zacks)
Jan-09-26 07:09PM	Why Liquidia Stock Rocked the Market Today (Motley Fool) +12.91%
06:30AM	Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update (GlobeNewswire)
11:40AM	Loading…
Jan-08-26 11:40AM	HRMY vs. LQDA: Which Stock Is the Better Value Option? (Zacks)
Jan-07-26 07:00AM	Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-25 09:06AM	Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus (Zacks)
Dec-11-25 09:22AM	Arquitos Capital Management's Updates on Liquidia Corporation (LQDA) (Insider Monkey)
Nov-24-25 09:55AM	Wall Street Analysts See a 51.15% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High? (Zacks)
Nov-21-25 12:04PM	United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base (Investor's Business Daily)
Nov-16-25 10:14PM	Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue (Insider Monkey)
Nov-06-25 09:55AM	Wall Street Analysts Think Liquidia Corporation (LQDA) Could Surge 62.34%: Read This Before Placing a Bet (Zacks)
Nov-05-25 06:39AM	Liquidia (LQDA) Climbs 10.7%, Nears 52-Week High on Strong Demand for Heart Treatment (Insider Monkey) -5.34%
Nov-03-25 04:02PM	Liquidia Corp (LQDA) Q3 2025 Earnings Call Highlights: Strong YUTREPIA Sales Drive Positive ... (GuruFocus.com) +10.67%
08:00AM	Loading…
08:00AM	Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences (GlobeNewswire)
06:30AM	Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-25 09:21AM	Liquidia Corp (LQDA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-25 04:14PM	United Therapeutics Rockets 10% On Growing Enthusiasm For Its Top Drug (Investor's Business Daily)
09:55AM	The Mixed Results For United Therapeutics' Bread-And-Butter Drug (Investor's Business Daily)
Oct-28-25 10:00AM	Niagen Bioscience (NAGE) Reports Next Week: What to Expect (Zacks)
09:35AM	Arcutis Biotherapeutics, Inc. (ARQT) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Oct-27-25 08:30AM	Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Oct-21-25 09:55AM	Wall Street Analysts Believe LIQUIDIA CORP (LQDA) Could Rally 50.94%: Here's is How to Trade (Zacks)
Oct-16-25 04:33PM	BofA Securities Raises Liquidia Corporation (LQDA) PT to $37, Reiterates Buy Rating (Insider Monkey)
Oct-07-25 06:30AM	Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 (GlobeNewswire) +5.10%
Oct-01-25 10:40AM	Is IPF the Next Big Market Opportunity for United Therapeutics? (Zacks)
Sep-29-25 08:30AM	Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting (GlobeNewswire)
Sep-24-25 04:06AM	Liquidia Corporation (LQDA) Presents Strategic Overview at Well Fargo's Annual Healthcare Conference 2025 (Insider Monkey)
Sep-23-25 10:32AM	Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares? (Insider Monkey)
02:15PM	Loading…
Sep-16-25 02:15PM	Liquidia Corporation (LQDA): A Bull Case Theory (Insider Monkey)
Sep-11-25 08:30AM	Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium (GlobeNewswire)
Sep-04-25 01:14PM	Jefferies Highlights Yutrepia's Market Edge in Supporting a Buy on Liquidia (LQDA) (Insider Monkey)
Sep-03-25 01:48PM	UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals (Zacks)
Sep-02-25 04:09PM	Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It (Investor's Business Daily)
09:34AM	Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It (Investor's Business Daily)
Sep-01-25 01:04AM	BTIG Raises Price Target for Liquidia (LQDA), Keeps Buy Rating (Insider Monkey)
Aug-27-25 08:30AM	Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-18-25 11:40PM	Court Victory and Fresh Funding Propel Growth at Liquidia Corporation (Insider Monkey) +6.82%
Aug-13-25 12:54PM	Liquidia (LQDA) Climbs 13.68% as Yutrepia Prescriptions Surge (Insider Monkey)
03:08AM	Liquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YUTREPIA Launch and Financial Position (GuruFocus.com)
Aug-12-25 04:06PM	Liquidia Shoots Higher As Yutrepia Launch Kicks Off Amid United Patent Battle (Investor's Business Daily) +13.68%
03:00PM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
10:00AM	Liquidia Shoots Higher, But At-Risk Launch Could Come Back To Haunt It (Investor's Business Daily)
06:30AM	Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-11-25 09:22AM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q2 2025 Result (GuruFocus.com)
Aug-05-25 08:30AM	Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire)
Jul-31-25 09:15AM	Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Jul-24-25 08:00AM	Insmed Is Trading At A 25-Year High. Will Its 'Skeleton Key' Work? (Investor's Business Daily) +5.75%
Jul-15-25 01:08PM	Liquidia Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
08:59AM	Liquidia Receives $50M from HCRx, Accelerates YUTREPIA's Commercial Launch Following Favorable Court Ruling (Insider Monkey)
Jun-23-25 04:34PM	Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA (GlobeNewswire)
Jun-11-25 11:04AM	Insmed Stock Jumps 29% on Encouraging PAH Study Results (Zacks) -5.67%
Jun-10-25 04:07PM	Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia (Investor's Business Daily) -16.87%
Jun-02-25 06:30AM	Liquidia Schedules First Commercial Shipment of YUTREPIA (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD (GlobeNewswire) +13.07%
May-28-25 08:00AM	Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference (GlobeNewswire) -9.13%
May-24-25 10:47AM	FDA Approves Liquidia Corporation (LQDA)'s YUTREPIA Amid Patent Dispute (Insider Monkey)
May-23-25 02:28PM	U.S. FDA Approves Liquidia's YUTREPIA (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) (GlobeNewswire)
May-12-25 06:00AM	Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics (GlobeNewswire)
May-09-25 03:21AM	Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... (GuruFocus.com)
May-08-25 11:06AM	Buckley Capital's Views on Liquidia Corp. (LQDA) (Insider Monkey)
07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
May-07-25 06:35PM	Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
11:16AM	Liquidia Q1 2025 Earnings Preview (Seeking Alpha)
10:15AM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result (GuruFocus.com)
May-06-25 08:00AM	Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference (GlobeNewswire)
May-05-25 04:06PM	Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month (Seeking Alpha)
09:50AM	Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains? (Zacks)
May-02-25 05:28PM	District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia (GlobeNewswire) +13.23%
May-01-25 08:00AM	Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-30-25 09:30AM	Arquitos Capital's Largest Holdings For Q1 2025 (Seeking Alpha)
Apr-29-25 07:40AM	Regeneron (REGN) Lags Q1 Earnings and Revenue Estimates (Zacks) -5.06%
05:16AM	Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last? (Zacks)
Apr-25-25 06:30AM	Arquitos Capital Management Q1 2025 Investor Letter (Seeking Alpha)
Apr-07-25 06:38AM	Liquidia: United Therapeutics Has The Last Laugh (Seeking Alpha)
Apr-01-25 10:33AM	UPDATE Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
08:00AM	Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-28-25 09:30AM	Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA (treprostinil) Inhalation Powder (GlobeNewswire)
Mar-27-25 08:00AM	Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference (GlobeNewswire)
Mar-21-25 06:23PM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result (GuruFocus.com)
Mar-20-25 01:01AM	Q4 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-19-25 11:56AM	Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript (SeekingAlpha)
07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-18-25 08:00AM	Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million (GlobeNewswire)
Mar-12-25 08:00AM	Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025 (GlobeNewswire)
Feb-24-25 07:00AM	Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors (GlobeNewswire)
Jan-22-25 09:12AM	Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Jan-08-25 08:00AM	Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-27-24 07:11PM	Jim Cramer's Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know (Insider Monkey)
Dec-12-24 10:00AM	Heres Arquitos Capital Managements Updates on Liquidia (LQDA) (Insider Monkey)
09:55AM	Does Liquidia Technologies (LQDA) Have the Potential to Rally 132.54% as Wall Street Analysts Expect? (Zacks)
Nov-26-24 09:55AM	Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High? (Zacks)
Nov-14-24 02:09AM	Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ... (GuruFocus.com)
Nov-13-24 07:40AM	Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-12-24 08:00AM	Liquidia to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-08-24 07:04AM	Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result (GuruFocus.com)

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boyle Dana	Chief Accounting Officer	Jan 26 '26	Sale	41.65	1,580	65,807	178,848	Jan 28 04:30 PM
Adair Jason	Chief Business Officer	Jan 26 '26	Sale	41.65	688	28,655	211,169	Jan 28 04:30 PM
Krepp Sarah	Chief Human Resource Officer	Jan 12 '26	Sale	37.43	13,165	492,766	140,769	Jan 13 04:36 PM
Moomaw Scott	Chief Commercial Officer	Jan 12 '26	Sale	37.43	20,533	768,550	154,514	Jan 13 04:36 PM
Kaseta Michael	CFO and COO	Jan 12 '26	Sale	37.43	36,932	1,382,365	350,919	Jan 13 04:34 PM
Adair Jason	Chief Business Officer	Jan 12 '26	Sale	37.43	13,548	507,102	184,174	Jan 13 04:34 PM
Schundler Russell	General Counsel	Jan 12 '26	Sale	37.43	27,289	1,021,427	579,394	Jan 13 04:33 PM
JEFFS ROGER	Chief Executive Officer	Jan 12 '26	Sale	37.43	66,610	2,493,212	1,037,528	Jan 13 04:33 PM
Boyle Dana	Chief Accounting Officer	Jan 12 '26	Sale	37.43	11,047	413,489	156,700	Jan 13 04:31 PM
Saggar Rajeev	Chief Medical Officer	Jan 12 '26	Sale	37.43	21,142	791,345	176,883	Jan 13 04:31 PM
Schundler Russell	General Counsel	Dec 01 '25	Sale	32.19	1,072	34,508	577,288	Dec 02 04:34 PM
Krepp Sarah	Chief Human Resource Officer	Dec 01 '25	Sale	32.19	221	7,114	141,218	Dec 02 04:33 PM
Kaseta Michael	CFO and COO	Dec 01 '25	Sale	32.19	1,166	37,534	353,823	Dec 02 04:32 PM
Boyle Dana	Chief Accounting Officer	Dec 01 '25	Sale	32.19	303	9,754	155,031	Dec 02 04:31 PM
Adair Jason	Chief Business Officer	Dec 01 '25	Sale	32.19	693	22,308	175,868	Dec 02 04:31 PM
Moomaw Scott	Chief Commercial Officer	Dec 01 '25	Sale	32.19	831	26,750	154,506	Dec 02 04:30 PM
Adair Jason	Chief Business Officer	Nov 18 '25	Option Exercise	5.89	35,656	210,014	210,654	Nov 20 04:30 PM
Adair Jason	Chief Business Officer	Nov 18 '25	Sale	30.03	35,656	1,070,710	174,998	Nov 20 04:30 PM
JASON ADAIR	Officer	Nov 18 '25	Proposed Sale	28.40	35,656	1,012,630		Nov 18 04:23 PM
Boyle Dana	Chief Accounting Officer	Nov 07 '25	Sale	25.09	29,004	727,674	155,334	Nov 12 04:30 PM
Saggar Rajeev	Chief Medical Officer	Nov 05 '25	Sale	27.00	71,381	1,927,287	176,549	Nov 07 04:30 PM
Dana Boyle	Officer	Nov 07 '25	Proposed Sale	25.09	29,004	727,581		Nov 07 04:07 PM
Rajeev Saggar	Officer	Nov 05 '25	Proposed Sale	27.00	71,381	1,927,287		Nov 05 04:03 PM
Adair Jason	Chief Business Officer	Oct 27 '25	Sale	22.93	692	15,868	174,998	Oct 29 04:30 PM
Boyle Dana	Chief Accounting Officer	Oct 27 '25	Sale	22.93	1,073	24,604	184,338	Oct 29 04:30 PM
Schundler Russell	General Counsel	Oct 13 '25	Sale	23.41	7,839	183,511	576,017	Oct 15 04:36 PM
Kaseta Michael	CFO and COO	Oct 13 '25	Sale	23.41	11,630	272,258	352,646	Oct 15 04:34 PM
Moomaw Scott	Chief Commercial Officer	Oct 13 '25	Sale	23.41	4,900	114,709	153,462	Oct 15 04:34 PM
Saggar Rajeev	Chief Medical Officer	Oct 13 '25	Sale	23.41	5,327	124,705	247,930	Oct 15 04:33 PM
Boyle Dana	Chief Accounting Officer	Oct 13 '25	Sale	23.41	1,238	28,982	185,411	Oct 15 04:32 PM
JEFFS ROGER	Chief Executive Officer	Oct 13 '25	Sale	23.41	20,261	474,310	1,032,973	Oct 15 04:31 PM
Adair Jason	Chief Business Officer	Oct 13 '25	Sale	23.41	3,670	85,915	175,690	Oct 15 04:31 PM
Krepp Sarah	Chief Human Resource Officer	Oct 13 '25	Sale	23.41	1,691	39,586	141,439	Oct 15 04:30 PM
SINGH RAMAN	Director	Sep 15 '25	Option Exercise	2.55	45,524	115,865	76,779	Sep 17 04:30 PM
SINGH RAMAN	Director	Sep 15 '25	Sale	25.81	45,524	1,174,974	31,255	Sep 17 04:30 PM
RAMANDEEP SINGH	Director	Sep 15 '25	Proposed Sale	25.81	45,524	1,175,043		Sep 15 04:02 PM
SINGH RAMAN	Director	Sep 03 '25	Sale	29.42	7,500	220,650	31,255	Sep 05 04:30 PM
Singh Raman	Director	Sep 03 '25	Proposed Sale	29.42	7,500	220,650		Sep 03 04:34 PM
Moomaw Scott	Chief Commercial Officer	Sep 02 '25	Sale	28.63	70,692	2,023,671	155,254	Sep 03 04:33 PM
Schundler Russell	General Counsel	Sep 02 '25	Sale	29.05	1,063	30,880	580,098	Sep 03 04:33 PM
Krepp Sarah	Chief Human Resource Officer	Aug 29 '25	Sale	29.05	209	6,071	143,130	Sep 03 04:32 PM
Kaseta Michael	CFO and COO	Sep 02 '25	Sale	29.05	1,148	33,349	358,448	Sep 03 04:31 PM
Boyle Dana	Chief Accounting Officer	Aug 29 '25	Sale	29.05	296	8,599	186,649	Sep 03 04:30 PM
Manning Paul B	Director	Sep 02 '25	Sale	28.78	328,268	9,446,332	430,828	Sep 02 07:46 PM
Manning Paul B	Director	Aug 29 '25	Sale	27.62	188,232	5,198,968	759,096	Sep 02 07:46 PM
Manning Paul B	Director	Aug 28 '25	Sale	27.94	154,337	4,312,176	947,328	Sep 02 07:46 PM
Adair Jason	Chief Business Officer	Aug 28 '25	Sale	27.86	26,057	725,854	171,029	Sep 02 05:03 PM
Adair Jason	Chief Business Officer	Sep 02 '25	Sale	29.05	451	13,102	172,980	Sep 02 05:03 PM
Saggar Rajeev	Chief Medical Officer	Aug 28 '25	Sale	27.85	20,000	557,072	249,727	Sep 02 05:02 PM
SCOTT MOOMAW	Officer	Sep 02 '25	Proposed Sale	27.68	70,000	1,937,600		Sep 02 04:31 PM
Manning Paul B	Director	Aug 29 '25	Proposed Sale	27.60	947,328	26,146,253		Aug 29 04:18 PM
RAJEEV SAGGAR	Officer	Aug 28 '25	Proposed Sale	28.00	20,000	560,000		Aug 28 04:23 PM
JASON ADAIR	Officer	Aug 28 '25	Proposed Sale	28.00	26,057	729,596		Aug 28 04:19 PM
Manning Paul B	Director	Aug 28 '25	Proposed Sale	27.94	154,337	4,312,469		Aug 28 04:11 PM
Horobin Joanna	Director	Aug 19 '25	Sale	27.17	5,000	135,850	33,755	Aug 21 04:30 PM
Horobin Joanna	Director	Aug 19 '25	Proposed Sale	27.17	5,000	135,850		Aug 19 07:28 PM
Kaseta Michael	CFO and COO	Aug 15 '25	Sale	26.18	20,000	523,674	356,412	Aug 19 04:30 PM
Kaseta Michael	CFO and COO	Aug 05 '25	Sale	20.00	30,000	600,132	376,412	Aug 07 04:30 PM
MICHAEL KASETA	Officer	Aug 05 '25	Proposed Sale	19.48	50,000	974,000		Aug 05 05:02 PM
Adair Jason	Chief Business Officer	Jul 28 '25	Sale	19.54	454	8,871	193,180	Jul 30 04:31 PM
Boyle Dana	Chief Accounting Officer	Jul 28 '25	Sale	19.54	1,063	20,771	186,105	Jul 30 04:30 PM
Saggar Rajeev	Chief Medical Officer	Jul 21 '25	Sale	14.54	2,526	36,728	268,887	Jul 23 04:30 PM
Schundler Russell	General Counsel	Jul 14 '25	Sale	14.28	7,836	111,898	577,977	Jul 15 04:36 PM
Saggar Rajeev	Chief Medical Officer	Jul 14 '25	Sale	14.28	5,327	76,070	271,413	Jul 15 04:36 PM
Moomaw Scott	Chief Commercial Officer	Jul 14 '25	Sale	14.28	4,797	68,501	223,231	Jul 15 04:35 PM
Krepp Sarah	Chief Human Resource Officer	Jul 14 '25	Sale	14.28	2,673	38,170	142,499	Jul 15 04:35 PM
Kaseta Michael	CFO and COO	Jul 14 '25	Sale	14.28	11,580	165,362	406,412	Jul 15 04:34 PM
JEFFS ROGER	Chief Executive Officer	Jul 14 '25	Sale	14.28	20,252	289,199	1,038,560	Jul 15 04:33 PM
JEFFS ROGER	Chief Executive Officer	Jul 14 '25	Sale	14.28	20,252	289,199	1,038,560	Jul 15 04:33 PM
Boyle Dana	Chief Accounting Officer	Jul 14 '25	Sale	14.28	1,193	17,036	187,168	Jul 15 04:30 PM
Adair Jason	Chief Business Officer	Jul 14 '25	Sale	14.28	2,576	36,785	193,634	Jul 15 04:30 PM
Schundler Russell	General Counsel	Jun 04 '25	Sale	16.97	8,460	143,566	582,054	Jun 05 04:20 PM
Moomaw Scott	Chief Commercial Officer	Jun 04 '25	Sale	16.97	6,656	112,952	224,921	Jun 05 04:20 PM
Saggar Rajeev	Chief Medical Officer	Jun 04 '25	Sale	16.97	7,597	128,921	273,209	Jun 05 04:19 PM
JEFFS ROGER	Chief Executive Officer	Jun 04 '25	Sale	16.97	30,610	519,452	1,044,979	Jun 05 04:18 PM
Kaseta Michael	CFO and COO	Jun 04 '25	Sale	16.97	14,777	250,766	412,164	Jun 05 04:18 PM
Adair Jason	Chief Business Officer	Jun 04 '25	Sale	16.97	3,597	61,041	193,735	Jun 05 04:15 PM
Schundler Russell	General Counsel	Jun 02 '25	Sale	16.74	923	15,451	571,722	Jun 03 04:49 PM
Moomaw Scott	Chief Commercial Officer	Jun 02 '25	Sale	16.74	581	9,726	216,038	Jun 03 04:47 PM
Kaseta Michael	CFO and COO	Jun 02 '25	Sale	16.74	859	14,380	397,800	Jun 03 04:45 PM
Adair Jason	Chief Business Officer	Jun 02 '25	Sale	16.74	451	7,550	184,961	Jun 03 04:44 PM
Adair Jason	Chief Business Officer	Apr 28 '25	Sale	14.24	455	6,479	183,849	Apr 30 04:15 PM
Saggar Rajeev	Chief Medical Officer	Apr 21 '25	Sale	13.67	2,450	33,492	263,152	Apr 23 04:15 PM
Schundler Russell	General Counsel	Apr 14 '25	Sale	13.57	5,964	80,931	570,301	Apr 16 05:06 PM
JEFFS ROGER	Chief Executive Officer	Apr 14 '25	Sale	13.57	14,130	191,744	1,006,420	Apr 16 05:05 PM
Moomaw Scott	Chief Commercial Officer	Apr 15 '25	Sale	13.57	3,406	46,219	214,744	Apr 16 05:04 PM
Kaseta Michael	CFO and COO	Apr 14 '25	Sale	13.57	8,283	112,400	396,315	Apr 16 05:03 PM
Saggar Rajeev	Chief Medical Officer	Apr 14 '25	Sale	13.57	3,714	50,399	265,602	Apr 16 05:02 PM
Adair Jason	Chief Business Officer	Apr 14 '25	Sale	13.57	1,856	25,186	184,304	Apr 15 09:12 PM
Schundler Russell	General Counsel	Mar 03 '25	Sale	15.45	930	14,368	576,265	Mar 04 04:32 PM
Moomaw Scott	Chief Commercial Officer	Mar 03 '25	Sale	15.45	592	9,146	218,150	Mar 04 04:31 PM
Kaseta Michael	CFO and COO	Mar 03 '25	Sale	15.45	874	13,503	404,598	Mar 04 04:31 PM
Adair Jason	Chief Business Officer	Mar 03 '25	Sale	15.45	451	6,968	182,254	Mar 04 04:30 PM

Open in Screener

CDLX

Cardlytics Inc

Feb 06 • 04:00PM ET

0.9062

+0.0413 4.78 %

Communication Services • Advertising Agencies • USA • NASD

Peers: TTD PERI MGNI APPS TTEC MCHX OPT FLNT PUBM MRIN

| Held by: VTI VXF VOX PRFZ IWC DFAS

Index	-	P/E	-	EPS (ttm)	-2.10	Insider Own	5.34%	Shs Outstand	53.81M	Perf Week	-6.43%
Market Cap	48.99M	Forward P/E	-	EPS next Y	-0.84	Insider Trans	-17.35%	Shs Float	51.17M	Perf Month	-36.63%
Enterprise Value	226.46M	PEG	-	EPS next Q	-0.21	Inst Own	41.83%	Short Float	11.49%	Perf Quarter	-48.51%
Income	-110.83M	P/S	0.20	EPS this Y	48.68%	Inst Trans	-3.99%	Short Ratio	6.66	Perf Half Y	-30.29%
Sales	251.18M	P/B	-	EPS next Y	58.31%	ROA	-32.02%	Short Interest	5.88M	Perf YTD	-21.20%
Book/sh	-0.09	P/C	1.11	EPS next 5Y	-	ROE	-341.04%	52W High	3.62 -74.93%	Perf Year	-70.96%
Cash/sh	0.81	P/FCF	-	EPS past 3/5Y	0.66% -40.23%	ROIC	-65.56%	52W Low	0.80 13.64%	Perf 3Y	-88.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	1.38% 5.75%	Gross Margin	45.53%	Volatility	11.83% 9.62%	Perf 5Y	-99.27%
Dividend TTM	-	EV/Sales	0.90	EPS Y/Y TTM	65.67%	Oper. Margin	-19.84%	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.14	Sales Y/Y TTM	-14.41%	Profit Margin	-44.12%	RSI (14)	36.10	Recom	3.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.14	EPS Q/Q	53.18%	SMA20	-17.73%	Beta	1.05	Target Price	1.62
Payout	-	Debt/Eq	-	Sales Q/Q	-22.41%	SMA50	-20.41%	Rel Volume	0.47	Prev Close	0.86
Employees	454	LT Debt/Eq	-	Earnings	Nov 05 AMC	SMA200	-43.09%	Avg Volume	882.85K	Price	0.91
IPO	Feb 09, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-316.28% -4.60%	Trades		Volume	417,673	Change	4.78%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-11-24	Initiated	Evercore ISI	In-line	$4
Aug-16-24	Downgrade	Northland Capital	Outperform → Market Perform	$5
Aug-15-24	Downgrade	BofA Securities	Neutral → Underperform	$4 → $3.50
Aug-08-24	Downgrade	Needham	Buy → Hold
Aug-08-24	Downgrade	Lake Street	Buy → Hold	$18 → $5
Aug-08-24	Downgrade	Craig Hallum	Buy → Hold
Jun-20-24	Resumed	BofA Securities	Neutral	$11
Jun-18-24	Initiated	Northland Capital	Outperform	$14
Mar-15-24	Upgrade	Craig Hallum	Hold → Buy	$10 → $18
Nov-29-23	Initiated	Lake Street	Buy	$13
Sep-08-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$14 → $13
Jul-14-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$72 → $15
Jul-13-22	Downgrade	BofA Securities	Neutral → Underperform	$14
Jul-12-22	Downgrade	Craig Hallum	Buy → Hold	$50 → $20
Apr-05-22	Resumed	Wells Fargo	Overweight	$72
Jun-18-21	Initiated	Needham	Buy	$135
Apr-15-21	Upgrade	Wells Fargo	Equal Weight → Overweight	$150
Apr-14-21	Upgrade	Craig Hallum	Hold → Buy	$145
Mar-05-21	Upgrade	BofA Securities	Underperform → Neutral	$128
Jan-14-21	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Jan-27-26 07:36AM	PAR Technology to buy Bridg to unite loyalty and instore data (Verdict Food Service)
Jan-26-26 08:02AM	PAR Technology to Acquire Bridg, Bringing Loyalty and Non-Loyalty Data Together for Smarter Retail and Restaurant Activation (Business Wire)
Jan-16-26 04:05PM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-05-26 12:00PM	Cardlytics (CDLX) Upgraded to Buy: Here's What You Should Know (Zacks) +10.71%
Dec-18-25 08:10AM	Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer (Business Wire)
12:00PM	Loading…
Nov-10-25 12:00PM	All You Need to Know About Cardlytics (CDLX) Rating Upgrade to Buy (Zacks)
Nov-06-25 12:09AM	Cardlytics Inc (CDLX) Q3 2025 Earnings Call Highlights: Navigating Challenges and Expanding ... (GuruFocus.com) -28.41%
Nov-05-25 05:02PM	Cardlytics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Cardlytics Announces Third Quarter 2025 Financial Results (Business Wire)
Oct-22-25 04:05PM	Cardlytics Announces Timing of Its Third Quarter 2025 Earnings Release (Business Wire) +7.81%
Oct-02-25 08:05AM	Cardlytics Announces Workforce Reductions As Part Of Organizational Realignment and Cost Savings Initiative (Business Wire)
Sep-19-25 09:06AM	Intel, Fedex, Cardlytics, Brera, : Trending Stocks (Yahoo Finance Video) -11.80%
Aug-14-25 10:30AM	Cardlytics Named Best Digital Ad Network in 2025 MarTech Breakthrough Awards Program (Business Wire) -7.63%
Aug-06-25 06:20PM	Cardlytics (CDLX) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -26.14%
05:17PM	Cardlytics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Cardlytics Announces Second Quarter 2025 Financial Results (Business Wire)
Aug-05-25 08:35AM	Blade Air Mobility, Inc. (BLDE) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.12%
Aug-01-25 04:05PM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.84%
Jul-30-25 09:30AM	Hy-Vee's RedMedia Joins the Rippl Retail Media Network (Business Wire)
Jul-23-25 04:05PM	Cardlytics Announces Timing of Its Second Quarter 2025 Earnings Release (Business Wire) +9.47% -13.30%
Jul-15-25 09:30AM	Cardlytics Introduces New Customer Insights Dashboards Within the Cardlytics Insights Portal (Business Wire)
Jul-04-25 08:50AM	Cardlytics (CDLX) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Jul-03-25 07:29AM	Loyalty, affordability drives UK fashion spend in Q1 2025 (Just Style)
May-20-25 09:30AM	Cardlytics Launches Cardlytics Rewards Platform and Expands Publisher Base Beyond Financial Institutions (Business Wire)
May-08-25 03:36AM	Cardlytics Inc (CDLX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and New Metrics ... (GuruFocus.com) -12.04%
May-07-25 10:52PM	Cardlytics outlines platform expansion with new partners and CRP launch in Q2 2025 (Seeking Alpha)
10:50PM	Cardlytics, Inc. (CDLX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:50PM	Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:47PM	Cardlytics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Cardlytics Announces First Quarter 2025 Financial Results (Business Wire)
08:45AM	Loading…
May-06-25 08:45AM	Priority Technology (PRTH) Surpasses Q1 Earnings Estimates (Zacks)
Apr-30-25 09:00AM	TTV Capital Adds Lynne Laube and Rachel Hamilton as Venture Partners (PR Newswire)
Apr-25-25 04:05PM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.21%
Apr-23-25 04:05PM	Cardlytics Announces Timing of Its First Quarter 2025 Earnings Release (Business Wire)
Mar-19-25 11:07AM	Coherent Stock Falls 22% in 6 Months: Is This a Buying Opportunity? (Zacks)
Mar-13-25 07:20PM	Closing Bell Movers: Intel spikes 11% after naming new CEO (TipRanks) +19.32%
06:36AM	Q4 2024 Cardlytics Inc Earnings Call (Thomson Reuters StreetEvents)
03:09AM	Cardlytics Inc (CDLX) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Mar-12-25 05:20PM	Cardlytics (CDLX) Reports Break-Even Earnings for Q4 (Zacks)
04:28PM	Cardlytics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-28-25 04:05PM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.20% -6.84%
Feb-26-25 04:05PM	Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2024 Earnings Release (Business Wire) -6.37%
Feb-25-25 11:27AM	Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman (PR Newswire)
Feb-20-25 10:43AM	Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman (Newsfile) -5.13%
Feb-18-25 05:45AM	Investors in Cardlytics, Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - CDLX (PR Newswire) -5.34%
Feb-13-25 08:18AM	Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman (Newsfile)
Feb-06-25 09:45AM	Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman (Newsfile) +5.45%
Jan-31-25 03:27AM	Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman (Newsfile)
Dec-17-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Cardlytics (CDLX) (Zacks)
Dec-06-24 03:33PM	Why Is Cardlytics, Inc. (CDLX) Among The Best Advertising Stocks to Buy According to Hedge Funds? (Insider Monkey)
Nov-07-24 12:01PM	Cardlytics Inc (CDLX) Q3 2024 Earnings Call Highlights: Navigating Challenges and Leveraging ... (GuruFocus.com) -21.88%
Nov-06-24 05:15PM	Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +11.09%
04:09PM	Cardlytics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Cardlytics Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-29-24 07:30AM	23andMe Appoints Three New Independent Directors to Board (GlobeNewswire)
Oct-23-24 04:01PM	Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release (GlobeNewswire)
Sep-30-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Cardlytics, Medpace, Customers Bancorp, and Ibotta and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-29-24 05:08AM	Is Cardlytics, Inc. (CDLX) the Worst Advertising Stock to Buy According to Short Sellers? (Insider Monkey)
Sep-27-24 12:12PM	Is Cardlytics, Inc. (CDLX) the Worst Marketing Stock to Buy? (Insider Monkey)
Sep-26-24 08:45AM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives Hagens Berman (GlobeNewswire)
Sep-24-24 05:25PM	Cardlytics, Inc. (CDLX): A Bull Case Theory (Insider Monkey)
Sep-16-24 05:52PM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives Hagens Berman (GlobeNewswire)
Sep-05-24 03:17PM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives Hagens Berman (GlobeNewswire)
Sep-03-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Bumble, Cardlytics, and NuScale and Encourages Investors to Contact the Firm (GlobeNewswire) -7.93%
Aug-29-24 12:05PM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives Hagens Berman (GlobeNewswire)
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-19-24 04:58PM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives Hagens Berman (GlobeNewswire) +7.24%
04:05PM	Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 10:51AM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives - Hagens Berman (Newsfile)
Aug-13-24 06:34PM	Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives Hagens Berman (GlobeNewswire) +8.81%
Aug-12-24 11:31PM	Director Scott Hill Acquires 40,000 Shares of Cardlytics Inc (CDLX) (GuruFocus.com) -6.88%
Aug-07-24 07:03PM	Cardlytics: Q2 Earnings Snapshot (Associated Press Finance) -5.74% -57.10%
04:13PM	Cardlytics Announces Second Quarter 2024 Financial Results (GlobeNewswire)
04:10PM	Cardlytics Appoints Amit Gupta as CEO (GlobeNewswire)
Jul-24-24 04:05PM	Cardlytics Announces Timing of Its Second Quarter 2024 Earnings Release (GlobeNewswire) -8.42%
Jun-05-24 03:04AM	Insider Sale: CEO Karim Temsamani Sells 43,129 Shares of Cardlytics Inc (CDLX) (GuruFocus.com) +10.81%
Jun-04-24 09:00AM	Giant Eagle's Leap Media Group Joins The Rippl Data & Media Network (GlobeNewswire)
May-29-24 08:03AM	Digital Turbine, Inc. (NASDAQ:APPS) Q4 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:54PM	Cardlytics Inc (CDLX) Reports Q1 2024 Earnings: A Detailed Analysis (GuruFocus.com)
May-09-24 02:38PM	Why Cardlytics Stock Collapsed on Thursday (Motley Fool) -36.51%
10:24AM	Cardlytics, Inc. (NASDAQ:CDLX) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:43AM	Why Is Cardlytics (CDLX) Stock Down 29% Today? (InvestorPlace)
07:50AM	Q1 2024 Cardlytics Inc Earnings Call (Thomson Reuters StreetEvents)
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
03:54AM	Cardlytics Inc (CDLX) Q1 2024 Earnings Call Transcript Highlights: A Mixed Bag of Growth and ... (GuruFocus.com)
May-08-24 04:47PM	Cardlytics: Q1 Earnings Snapshot (Associated Press Finance) -5.26%
04:05PM	Cardlytics Announces First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 04:05PM	Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.54% +6.51%
Apr-25-24 09:51AM	Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing (MT Newswires)
02:43AM	Cardlytics Inc (CDLX) COO Amit Gupta Sells 23,416 Shares (GuruFocus.com)
Apr-24-24 04:05PM	Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release (GlobeNewswire) -6.87%
Apr-15-24 09:30AM	5 Tech Stocks for Less Than $50 for April 2024 (Investopedia)
Apr-09-24 04:02PM	Liane Hornsey Appointed to Cardlytics Board of Directors (GlobeNewswire) -6.98%
Apr-03-24 01:52AM	Cardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 Shares (GuruFocus.com)
01:52AM	Cardlytics Inc (CDLX) Chief Legal & Privacy Officer Nicholas Lynton Sells 12,460 Shares (GuruFocus.com)
Apr-02-24 05:53PM	Why Cardlytics Stock Skyrocketed 75% Last Month (Motley Fool) -5.60%
Mar-26-24 09:15PM	Cardlytics Prices $150.0 Million Convertible Senior Notes Offering (GlobeNewswire) -32.84% +7.65%
06:41PM	Why Cardlytics Stock Tanked by 33% Today (Motley Fool)
07:13AM	Cardlytics Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Jan 05 '26	Sale	1.17	6,253	7,316	122,862	Jan 05 06:56 PM
Gupta Amit	Chief Executive Officer	Jan 05 '26	Sale	1.17	5,807	6,794	506,852	Jan 05 06:53 PM
DeSieno Alexis	Chief Financial Officer	Jan 05 '26	Sale	1.17	8,607	10,070	201,159	Jan 05 06:47 PM
DeSieno Alexis	Officer	Jan 05 '26	Proposed Sale	1.17	8,607	10,073		Jan 05 04:44 PM
Gupta Amit	Officer	Jan 05 '26	Proposed Sale	1.17	5,807	6,796		Jan 05 04:38 PM
Lynton Nicholas Hollmeyer	Officer	Jan 05 '26	Proposed Sale	1.17	6,253	7,318		Jan 05 04:23 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Oct 02 '25	Sale	2.27	6,098	13,849	116,327	Oct 02 07:07 PM
Gupta Amit	Chief Executive Officer	Oct 02 '25	Sale	2.27	7,799	17,712	498,310	Oct 02 07:05 PM
DeSieno Alexis	Chief Financial Officer	Oct 02 '25	Sale	2.27	8,493	19,288	195,417	Oct 02 07:02 PM
DeSieno Alexis	Officer	Oct 02 '25	Proposed Sale	2.27	8,493	19,287		Oct 02 04:19 PM
Gupta Amit	Officer	Oct 02 '25	Proposed Sale	2.27	7,799	17,711		Oct 02 04:17 PM
Lynton Nicholas Hollmeyer	Officer	Oct 02 '25	Proposed Sale	2.27	6,098	13,848		Oct 02 04:10 PM
SOSIN CLIFFORD	10% Owner	Aug 18 '25	Sale	1.14	200,000	228,220	5,399,023	Aug 19 08:22 PM
SOSIN CLIFFORD	10% Owner	Aug 19 '25	Sale	1.12	200,000	224,540	5,199,023	Aug 19 08:22 PM
Gupta Amit	Chief Executive Officer	Aug 18 '25	Sale	1.12	68,260	76,792	560,444	Aug 19 06:44 PM
Gupta Amit	Chief Executive Officer	Aug 19 '25	Sale	1.12	68,685	76,790	491,759	Aug 19 06:44 PM
Gupta Amit	Officer	Aug 19 '25	Proposed Sale	1.12	68,685	76,804		Aug 19 03:16 PM
Gupta Amit	Officer	Aug 18 '25	Proposed Sale	1.13	68,260	76,806		Aug 18 04:38 PM
DeSieno Alexis	Chief Financial Officer	Aug 15 '25	Sale	1.22	26,048	31,700	189,560	Aug 18 04:07 PM
DeSieno Alexis	Officer	Aug 15 '25	Proposed Sale	1.22	26,048	31,695		Aug 15 03:11 PM
Gupta Amit	Chief Executive Officer	Jul 02 '25	Sale	1.78	6,725	11,988	378,704	Jul 02 06:37 PM
DeSieno Alexis	Chief Financial Officer	Jul 02 '25	Sale	1.78	7,324	13,056	171,858	Jul 02 06:36 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Jul 02 '25	Sale	1.78	5,271	9,396	109,636	Jul 02 06:36 PM
DeSieno Alexis	Officer	Jul 02 '25	Proposed Sale	1.78	7,324	13,056		Jul 02 04:45 PM
Gupta Amit	Officer	Jul 02 '25	Proposed Sale	1.78	6,725	11,988		Jul 02 04:23 PM
Lynton Nicholas Hollmeyer	Officer	Jul 02 '25	Proposed Sale	1.78	5,271	9,396		Jul 02 04:18 PM
Hill Scott A	Director	May 23 '25	Option Exercise	0.00	11,000	0	57,748	May 23 07:37 AM
Francis Jonathan Edward	Director	May 23 '25	Option Exercise	0.00	11,000	0	15,310	May 23 07:35 AM
Klinck John L. Jr.	Director	May 23 '25	Option Exercise	0.00	11,000	0	78,593	May 23 07:34 AM
Fernandez Andre J	Director	May 23 '25	Option Exercise	0.00	11,000	0	15,310	May 23 07:33 AM
DeSieno Alexis	Chief Financial Officer	May 15 '25	Sale	1.94	26,217	50,809	164,833	May 16 04:03 PM
DeSieno Alexis	Officer	May 15 '25	Proposed Sale	1.94	26,217	50,809		May 15 03:17 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Apr 22 '25	Sale	1.51	303	458	102,119	Apr 22 08:27 PM
Lynton Nicholas Hollmeyer	Officer	Apr 22 '25	Proposed Sale	1.51	303	458		Apr 22 03:14 PM
Gupta Amit	Chief Executive Officer	Apr 02 '25	Sale	1.81	7,342	13,260	371,080	Apr 03 04:12 PM
DeSieno Alexis	Chief Financial Officer	Apr 02 '25	Sale	1.81	7,998	14,444	147,300	Apr 03 04:11 PM
Lynton Nicholas Hollmeyer	Chief Legal & Privacy Officer	Apr 02 '25	Sale	1.81	5,754	10,392	101,740	Apr 03 04:10 PM
Lynton Nicholas Hollmeyer	Officer	Apr 02 '25	Proposed Sale	1.81	5,754	10,394		Apr 02 04:36 PM
DeSieno Alexis	Officer	Apr 02 '25	Proposed Sale	1.81	7,998	14,448		Apr 02 04:23 PM
Gupta Amit	Officer	Apr 02 '25	Proposed Sale	1.81	7,342	13,263		Apr 02 04:22 PM
Gupta Amit	Chief Executive Officer	Feb 19 '25	Sale	3.18	54,565	173,462	364,072	Feb 19 06:28 PM
Gupta Amit	Chief Executive Officer	Feb 18 '25	Sale	3.40	46,857	159,220	418,637	Feb 19 06:28 PM
Gupta Amit	Officer	Feb 19 '25	Proposed Sale	3.18	54,565	173,478		Feb 19 04:30 PM
DeSieno Alexis	Chief Financial Officer	Feb 18 '25	Sale	3.40	24,778	84,196	140,948	Feb 18 06:39 PM
Gupta Amit	Officer	Feb 18 '25	Proposed Sale	3.40	46,857	159,225		Feb 18 04:29 PM
DeSieno Alexis	Officer	Feb 18 '25	Proposed Sale	3.40	24,778	84,198		Feb 18 04:18 PM

LQDA

Liquidia Corp

CDLX

Cardlytics Inc

Upgrade your FINVIZ experience